Abstract
Prodrugs of antimicrobial peptides can be generated by modifying their sequences at their N-termini with a linker and a negatively charged promoiety. These modifications can be selectively reversed by a disease-associated enzyme, thereby confining the activity of the peptide to pathologically affected body parts. A general method for the generation of prodrug candidates, based on a linker constituting the substrate of a disease-associated protease and an oligo-glutamic acid promoiety, as well as a protocol to validate the activation of the prodrug, are described herein.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Rautio J, Kumpulainen H, Heimbach T et al (2008) Prodrugs: design and clinical applications. Nat Rev Drug Discov 7:255–270
Stella VJ (2004) Prodrugs as therapeutics. Exp Opin Ther Patents 14:277–280
Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389–395
Desgranges S, Ruddle CC, Burke LP et al (2012) β-Lactam-host defence peptide conjugates as antibiotic prodrug candidates targeting resistant bacteria. RSC Adv 2:2480–2492
Kennedy DA, Vembu N, Fronczek FR et al (2011) Synthesis of mutual azo prodrugs of anti-inflammatory agents and peptides facilitated by α-aminoisobutyric acid. J Org Chem 76:9641–9647
Desgranges S, Le Prieult F, Daly A et al (2011) In vitro activities of synthetic host defense propeptides processed by neutrophil elastase against cystic fibrosis pathogens. Antimicrob Agents Chemother 55:2487–2489
Forde É, Schütte A, Reeves E et al (2016) Differential in vitro and in vivo toxicities of antimicrobial peptide prodrugs for potential use in cystic fibrosis. Antimicrob Agents Chemother 60:2813–2821
Smyth TP, O’Donnell ME, O’Connor MJ et al (2000) β-lactamase-dependent prodrugs - recent developments. Tetrahedron 56:5699–5707
Hu Q, Katti PS, Gu Z (2014) Enzyme-responsive nanomaterials for controlled drug delivery. Nanoscale 21:12273–12286
Merrifield RB (1986) Solid phase synthesis. Science 232:341–347
Hyde C, Johnson T, Owen D et al (1994) Some ‘difficult sequences’ made easy. A study of interchain association in solid phase peptide synthesis. Int J Pept Protein Res 43:431–440
Mergler M, Dick F, Sax B et al (2003) The aspartimide problem in Fmoc-based SPPS. Part II. J Pept Sci 9:518–526
Dubin G (2002) Extracellular proteases of Staphylococcus spp. Biol Chem 383:1075–1086
Hensbergen PJ, Klychnikov O, Bakker D et al (2014) A novel secreted metalloprotease (CD2830) from Clostridium difficile cleaves specific proline sequences in LPXTG cell surface proteins. Mol Cell Proteomics 5:1231–1244
Fields GB (2010) Using fluorogenic peptide substrates to assay matrix metalloproteinases. Methods Mol Biol 622:393–433
Hansen PR, Oddo A (2015) Fmoc solid-phase peptide synthesis. Methods Mol Biol 1348:33–50
Pedersen SL, Jensen KJ (2013) Instruments for automated peptide synthesis. Methods Mol Biol 1047:215–224
Acknowledgements
This material is based upon works supported by the Science Foundation Ireland under Grants 05/RFP/CHE0063, 06/RFP/CHO024, 06/RFP/CHO024/EC07 and SFI 08/RFP/CHE1563, Enterprise Ireland under Grant PC/2005/164, RCSI under the RCSI Student Research Programme and the Higher Education Authority, Ireland under the BioAT programme in Cycle 5 of the Programme for Research in Third-Level Institutions.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Forde, É.B., Kelly, G., Makki, H., Al-Sharshahi, Z., Fitzgerald-Hughes, D., Devocelle, M. (2017). Using Disease-Associated Enzymes to Activate Antimicrobial Peptide Prodrugs. In: Hansen, P. (eds) Antimicrobial Peptides. Methods in Molecular Biology, vol 1548. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6737-7_26
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6737-7_26
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6735-3
Online ISBN: 978-1-4939-6737-7
eBook Packages: Springer Protocols